News in Numbers

Prevention and screening for the five most common cancers averted 4.75 million deaths between 1975-2020, according to new research by the National Institutes of Health.

Eli Lilly is investing $3bn to expand its newly acquired manufacturing facility in Wisconsin, US, extending the company’s global parenteral product manufacturing network.

Kronos Bio has announced that it plans to reduce its workforce by 83% by the end of 2024 as part of an ongoing strategy to reduce costs while evaluating different options to enhance stockholder value.

Vifor Pharma has offered to pay the UK’s National Health Service (NHS) £23m to resolve a CMA investigation into a restriction of competition through misinformation case.

Samsung Biologics has announced securing a $668m contract with a Europe-based pharmaceutical company.